Past Events
Tech Alliance State of Technology Luncheon
Mark your calendars for the 2023 Luncheon on May 25! We’re thrilled to have Mike Sievert, CEO of T-Mobile, as our featured speaker. Our annual State of Technology Luncheon is a not-to-be-missed event that attracts an exclusive group of more than 600 of the region’s top business, education, research, and government officials. Each year, we present important information comparing Washington state to the […]
SBIR 101
The Small Business Innovative Research (SBIR) program provides seed money to small businesses who are developing cutting edge technologies that may help federal agencies meet their research and development needs. If you are an R&D firm or developing high tech you may be a good match for this program. Our virtual presentation will cover the […]
Life Science Washington Spring Networking Event 2023
Join Life Science Washington for a happy hour at Art Marble 21 in the beautiful Bonfire Room and network with Seattle life sciences professionals. Enjoy delicious complimentary appetizers and drinks, full access to the game room where you can play pool, shuffleboard, ping pong, skee ball, and arcade games, and connect with others in our community. […]
Career Development Workshop: Preparing Scientists for Industry Careers
JOIN LIFE SCIENCE WASHINGTON FOR A FREE “LEARN BY DOING” WORKSHOP PRESENTED BY SCIPHD. About this Event Date: May 18, 19, 22, 23, 2023 Time: 12:00 – 4:00 PM PT With an increasing number of available jobs shifting from academia to industry settings, understanding the skills necessary to compete for and succeed in an industry position […]
NanoString Technologies Webinar – Detailed Mechanistic Understanding of Drug Activity by Combining Spatial Biology with Trackable Drug Microdosing in Patients with Solid Tumors
Join NanoString Technologies for a deep dive into NanoString’s spatial biology offerings. This webinar will discuss capabilities for both the GeoMx Digital Spatial Profiler (DSP) and CosMx Spatial Molecular Imager (SMI) for clinical studies. Guest speakers from Presage Biosciences will share a clinical trials case study. Tumor response to drug exposure is highly influenced by […]
Intellectual Property Symposium
Are you an inventor or researcher in the life sciences or medical device space looking to learn more about intellectual property issues? We invite you to participate in Intellectual Property Symposium on May 17. This half-day conference offers an in-depth examination of IP strategy, focusing on its consequences for new businesses, developing industries, and established […]
Ukrainian Startup Day
Sitting Down with Ukraine’s Startup Leaders: Stories From the Frontlines of the Country’s Innovation Ecosystem Ukraine’s startup and innovation ecosystem is brimming with highly skilled talent, entrepreneurship ingenuity and immensely creative, motivated leaders. Prior to Russia’s illegal invasion, the country was experiencing exciting momentum, and was on pace to become one of Europe’s fastest-growing tech […]
SBIR Grant Writing Workshop Part II – NIH Deep Dive
Join Life Science Washington Institute in May, for part two of our grant writing bootcamp to help demystify SBIR/STTR funding routes. This series is for anyone interested in learning more about SBIR and STTR funding opportunities and those who want to effectively compete for these awards to develop and commercialize innovative technologies. The bootcamp serves […]
Drug Development Immersion
Drug Development Immersion is a two-day interactive course that explores the regulatory, commercial, and scientific factors needed to bring a drug successfully to market. The discussion features both small molecule drugs and biologics. Our instructors illustrate the corporate decision-making process with personal accounts, giving participants unique strategic development insights. Learn from an industry expert what it […]
Seattle Rare Disease Fair
The Fair and Summit aim to educate, engage, and inspire our community about the importance of rare disease research. Our goal is for all attendees – including a diverse representation of patient advocates, patient organizations, pharma, biotech, government institutions, researchers, legislators, and payers – to better understand how they can help with ending the diagnostic […]